Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学HER2 Testing Standardization NSCLC

Lynette Sholl

MD

🏢Brigham and Women's Hospital / Dana-Farber🌐USA

Chief of Thoracic Pathology

80
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Lynette Sholl has led guideline development for molecular testing in lung cancer including HER2 detection via NGS, FISH, and IHC, harmonizing reporting standards across institutions. Her work supports accurate identification of HER2-mutant and HER2-amplified NSCLC for targeted therapy selection. She advances integration of multi-biomarker thoracic panels.

Share:

🧪Research Fields 研究领域

HER2 NGS detection NSCLC
HER2 testing guideline development
CAP-IASLC-AMP molecular testing
thoracic NGS workflows
HER2 exon 20 reporting

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Lynette Sholl 的研究动态

Follow Lynette Sholl's research updates

留下邮箱,当我们发布与 Lynette Sholl(Brigham and Women's Hospital / Dana-Farber)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment